Clearmind Medicine Inc. (CMND)

NASDAQ: CMND · Real-Time Price · USD

0.8137

+0.0767 (10.41%)

At close: Mar 27, 2026, 4:00 PM EDT

0.8300

+0.0163 (2.00%)

Pre-market: Mar 30, 2026, 8:56 AM EDT

Clearmind Medicine Income Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Selling, General & Admin	5.6	3.61	4.36	4.76	3.17	2.22
Research & Development	2.24	2.06	1.38	1.54	3.08	0.47
Total Operating Expenses	7.83	5.67	5.74	6.3	6.25	2.69
Operating Income	-7.83	-5.67	-5.74	-6.3	-6.25	-2.69
Interest Income	0.16	0.13	0.27	0.07	-	-
Other Non-Operating Income (Expense)	1.27	1.75	0.6	-2.39	-0.61	-0.02
Total Non-Operating Income (Expense)	1.44	1.88	0.87	-2.32	-0.61	-0.02
Pretax Income	-6.6	-3.79	-4.88	-8.6	-6.87	-2.73
Provision for Income Taxes	0.04	0.07	0.38	0.02	0.03	-
Net Income	-6.64	-3.86	-5.25	-8.62	-6.89	-2.73
Net Income to Common	-6.64	-3.86	-5.25	-8.62	-6.89	-2.73
Shares Outstanding (Basic)	0	0	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0	0	0
Shares Change (YoY)	305.23%	63.98%	1431.08%	367.24%	40.19%	70.50%
EPS (Basic)	-24.46	-30.35	-67.80	-1703.04	-6364.40	-3526.40
EPS (Diluted)	-24.46	-30.35	-67.80	-1703.04	-6364.40	-3526.40
Shares Outstanding	1.5	0.16	0.11	0.02	0	0
Free Cash Flow	-5.55	-4.73	-4.86	-6.3	-3.73	-2.09
Free Cash Flow Per Share	-14.26	-37.25	-62.69	-1244.86	-3443.00	-2709.79
EBITDA	-7.78	-5.62	-5.69	-6.25	-6.17	-2.69
EBIT	-7.83	-5.67	-5.74	-6.3	-6.25	-2.69
Effective Tax Rate	-0.53%	-1.86%	-7.75%	-0.20%	-0.43%	0.00%

Updated Jan 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q